OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. Various strategies can be employed maximize antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning growth parameters plays